Skip to content
Themes / Specialty Chemicals & Pharma Intermediates / Specialized Amines & Derivatives

Specialized Amines & Derivatives

2-player oligopoly serving pharma, agrochem, and water treatment

oligopolyaminesquality
Theme price path

Specialized Amines & Derivatives vs Nifty 500

Weekly basket performance over the latest 26 observations. Green is ahead of Nifty 500; red is behind.

Through 22 Oct 2026
Thin evidence
Theme aheadTheme behindNifty 500Base 100 at the first visible weekLatest: Outperforming +35.6%
8910812814716730 Apr 2026 | Specialized Amines & Derivatives 100.0 | Nifty 500 100.0 | In line 0.0% | breadth 100% | coverage 100%08 May 2026 | Specialized Amines & Derivatives 112.1 | Nifty 500 101.9 | Outperforming +10.0% | breadth 100% | coverage 100%15 May 2026 | Specialized Amines & Derivatives 120.8 | Nifty 500 99.3 | Outperforming +21.7% | breadth 100% | coverage 100%22 May 2026 | Specialized Amines & Derivatives 124.8 | Nifty 500 99.9 | Outperforming +24.9% | breadth 50% | coverage 100%29 May 2026 | Specialized Amines & Derivatives 120.7 | Nifty 500 99.9 | Outperforming +20.8% | breadth 0% | coverage 100%05 Jun 2026 | Specialized Amines & Derivatives 134.4 | Nifty 500 99.0 | Outperforming +35.8% | breadth 100% | coverage 100%12 Jun 2026 | Specialized Amines & Derivatives 139.5 | Nifty 500 99.6 | Outperforming +40.1% | breadth 100% | coverage 100%19 Jun 2026 | Specialized Amines & Derivatives 140.2 | Nifty 500 102.1 | Outperforming +37.3% | breadth 100% | coverage 100%26 Jun 2026 | Specialized Amines & Derivatives 133.1 | Nifty 500 101.9 | Outperforming +30.6% | breadth 0% | coverage 100%03 Jul 2026 | Specialized Amines & Derivatives 141.4 | Nifty 500 102.7 | Outperforming +37.7% | breadth 100% | coverage 100%10 Jul 2026 | Specialized Amines & Derivatives 153.5 | Nifty 500 103.0 | Outperforming +49.0% | breadth 100% | coverage 100%17 Jul 2026 | Specialized Amines & Derivatives 144.4 | Nifty 500 102.9 | Outperforming +40.3% | breadth 0% | coverage 100%24 Jul 2026 | Specialized Amines & Derivatives 139.3 | Nifty 500 101.1 | Outperforming +37.8% | breadth 0% | coverage 100%31 Jul 2026 | Specialized Amines & Derivatives 137.9 | Nifty 500 103.4 | Outperforming +33.4% | breadth 0% | coverage 100%07 Aug 2026 | Specialized Amines & Derivatives 138.7 | Nifty 500 104.5 | Outperforming +32.7% | breadth 50% | coverage 100%14 Aug 2026 | Specialized Amines & Derivatives 143.1 | Nifty 500 104.0 | Outperforming +37.6% | breadth 100% | coverage 100%21 Aug 2026 | Specialized Amines & Derivatives 146.3 | Nifty 500 103.6 | Outperforming +41.2% | breadth 50% | coverage 100%28 Aug 2026 | Specialized Amines & Derivatives 157.1 | Nifty 500 103.7 | Outperforming +51.5% | breadth 50% | coverage 100%04 Sept 2026 | Specialized Amines & Derivatives 160.5 | Nifty 500 102.5 | Outperforming +56.6% | breadth 50% | coverage 100%11 Sept 2026 | Specialized Amines & Derivatives 146.5 | Nifty 500 100.8 | Outperforming +45.3% | breadth 0% | coverage 100%18 Sept 2026 | Specialized Amines & Derivatives 143.0 | Nifty 500 100.7 | Outperforming +42.0% | breadth 0% | coverage 100%25 Sept 2026 | Specialized Amines & Derivatives 143.0 | Nifty 500 99.6 | Outperforming +43.6% | breadth 50% | coverage 100%01 Oct 2026 | Specialized Amines & Derivatives 134.4 | Nifty 500 96.4 | Outperforming +39.4% | breadth 0% | coverage 100%09 Oct 2026 | Specialized Amines & Derivatives 136.6 | Nifty 500 96.4 | Outperforming +41.7% | breadth 50% | coverage 100%16 Oct 2026 | Specialized Amines & Derivatives 138.8 | Nifty 500 98.2 | Outperforming +41.3% | breadth 100% | coverage 100%22 Oct 2026 | Specialized Amines & Derivatives 129.4 | Nifty 500 95.4 | Outperforming +35.6% | breadth 0% | coverage 100%Outperforming +35.6%30 Apr 202624 Jul 202622 Oct 2026
Theme return · 26W
+29.4%
Nifty 500 · 26W
-4.6%
Vs Nifty 500 · 26W
+35.6%
Latest coverage
2/2

Fewer than five constituents have adequate aligned history, so treat this plot as preliminary evidence.

How this plot is calculated

The theme line is green when its cumulative rebased performance is above Nifty 500 and red when it is below. The chart callout shows the latest relative performance as the theme level divided by the benchmark level, minus one.

The basket uses the theme's current reviewed companies. For each available week, we calculate every valid constituent's close-to-close return and give each company the same weight. If a weekly rollup is missing or lags the daily series, the final available daily close in that week is used; the last point can therefore be week-to-date.

For baskets with at least 10 valid stocks, the highest and lowest 5% of weekly returns are trimmed to reduce split, corporate-action, and single-stock distortions. Weekly basket returns are then compounded and rebased to 100 beside the Nifty 500.

Breadth is the share of valid constituents that rose that week. Coverage is the number with usable aligned prices divided by current membership. Weekly moves above 80% are excluded as likely data or corporate-action outliers.

Limitation: this is a current-membership historical reconstruction, not a point-in-time investable index. It can contain survivorship bias and excludes costs, liquidity impact, dividends, and rebalancing turnover.

Model note: Current-member weekly equal-weight returns (5% tails trimmed for baskets of 10+), compounded and rebased to 100 against Nifty 500. Rotation is anchored at 100 = Nifty 500 parity: the horizontal axis is 13-week excess return and the vertical axis is its four-week acceleration. Lagging weekly rollups are patched with the final available daily close, so the latest observation may be week-to-date.

Theme scorecard

Measures whether this idea is investable today by blending cohort quality, valuation cushion, and price momentum. It is a research filter, not advice.

Build portfolio from this theme
Theme
41
Stretched
Quality
32
Valuation
47
Momentum
51
Positive MoS
50%
P/E 38.5 · ROCE 26%

Thesis

The aliphatic amines market in India is essentially a duopoly between Alkyl Amines and Balaji Amines. Downstream demand is non-discretionary: pharma intermediates, agrochemicals, and water treatment. Import substitution + tight oligopoly structure → high ROCE even in cyclical troughs. Small cohort (2 pure-plays) but the quality of the structure compensates.

  • ▸Duopoly structure — Alkyl + Balaji control majority share
  • ▸Non-discretionary downstream demand (pharma + agro + water)
  • ▸High ROCE through the cycle
  • ▸Cohort is tiny — concentration risk if you play both equally

Top picks · ranked by U-Score within this cohort

The rationale above is editorial — the ranking uses our U-Score engine so the names you see first are the strongest fundamentals fit, not the most popular or most-mentioned. Re-rank yourself if you weigh valuation or quality differently. All information is for study purposes only — consult your financial advisor before investing.